Related Experiment Video
Updated: Apr 17, 2026
05:57
Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
1.3K
[Antihypertensive drug therapy : Where do we stand?].
1Hypertoniezentrum München, Excellence Centre of the European Society of Hypertension (ESH), Herzzentrum Alter Hof, Dienerstr. 12, 80331, München, Deutschland, info@hypertoniezentrum.de.
Der Internist
|February 25, 2015
Summary
Effective antihypertensive drug therapy has advanced significantly, with improved treatment options and adherence through fixed-dose combinations. Careful consideration of drug timing and individual blood pressure rhythms is crucial for optimal 24-hour control.
Area of Science:
- Cardiology and Pharmacology
- Hypertension Management
- Pharmacotherapy Research
Context:
- Antihypertensive drug therapy has seen substantial advancements, particularly in Germany.
- A broad spectrum of effective and well-tolerated antihypertensive medications is now available.
- Fixed-dose combination therapies are increasingly recognized for their efficacy and role in improving patient adherence.
Purpose:
- To review the current landscape of antihypertensive drug therapy.
- To highlight the benefits of combination therapy and fixed-dose formulations in improving medication adherence.
- To emphasize the critical role of timing and individual blood pressure rhythms in optimizing antihypertensive treatment efficacy.
Summary:
- Modern antihypertensive drug therapy offers numerous effective and well-tolerated options.
- Fixed-dose combination therapies enhance patient adherence by reducing the number of pills.
- The interpretation of studies on beta-blockers and renin-angiotensin-aldosterone system blockade requires careful consideration.
- Optimal antihypertensive treatment necessitates accounting for the time of day, measurement, and intake for 24-hour efficacy.
- Individualized blood pressure rhythms, including dose and timing, are essential for optimal therapeutic outcomes.
- Central (aortic) blood pressure is emerging as a key target for antihypertensive therapy.
Impact:
- Improved patient adherence and therapeutic outcomes through optimized combination therapies.
- Enhanced understanding of chronopharmacology in hypertension management, leading to more personalized treatment strategies.
- Potential for reduced cardiovascular morbidity and mortality with precisely timed and individualized antihypertensive regimens.
Related Concept Videos
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
926
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
926
01:16Antihypertensive Drugs: Action of Diuretics
2.8K
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
2.8K
01:23Hypertension V: Nursing Management
662
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
662
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
667
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
667
01:15Antihypertensive Drugs: Thiazide-Class Diuretics
2.4K
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
2.4K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.9K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.9K